NanJing Pharmaceutical Company Limited
600713.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.72B
Close$
$13.79
168.3% upside
Current Fair Value
168.3% upsideUndervalued by 168.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.72 Billion |
|---|---|
| Enterprise Value | $17.20 Billion |
| Dividend Yield | $0.17 (5.06%) |
| Earnings per Share | $0.48 |
| Beta | 0.23 |
| Outstanding Shares | 1,289,265,122 |
Return
| Return on Equity | 8.66% |
|---|---|
| Return on Assets | 1.73% |
| Return on Invested Capital | 11.00% |
Valuation & Multiples
| P/E Ratio | 10.67 |
|---|---|
| PEG | 203.11 |
| Price to Sales | 0.12 |
| Price to Book Ratio | 0.86 |
| Enterprise Value to Revenue | 0.31 |
| Enterprise Value to EBIT | 11.59 |
| Enterprise Value to Net Income | 27 |
| Total Debt to Enterprise | 0.78 |
| Debt to Equity | 1.85 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About NanJing Pharmaceutical Company Limited
4,697 employees
CEO: Liang Zhang Established in 1951 and headquartered in Nanjing, China, NanJing Pharmaceutical Company Limited specializes in the nationwide wholesale and retail distribution of pharmaceutical products. The company oversees a substantial network compri...